The data presented here suggest that in the absence of immune cells, B7-H3 could maintain cancer cell growth by regulating IMPDH2 localisation and potential activity, and subsequently the de novo purine biosynthetic pathway, resulting in increased GTP levels. The gene discussed is IMPDH2; the disease is cancer.